DYN FY 2013 Earnings — Dyne Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DYNDyne Therapeutics, Inc.

$3B

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+0.0% YoY

Gross Profit

-$1.1B-38066.7% margin

Operating Income

-$318M-10600.0% margin

Net Income

-$356M-11866.7% margin

EPS (Diluted)

$-3.56

Cash Flow

Operating Cash Flow

$175M

Free Cash Flow

$77M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$5.3B

Total Liabilities

$3.1B

Stockholders' Equity

$2.2B

Cash & Equivalents

$843M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	+0.0%
Gross Profit	-$1.1B	-$265M	-330.9%
Operating Income	-$318M	$714M	-144.5%
Net Income	-$356M	$87M	-509.2%